Does on-demand vardenafil improve erectile function recovery after radical prostatectomy?

Nature Clinical Practice Urology

Volumn 6, Issue 1, 2009, Pages 14-15

  Mulhall, John P ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; SILDENAFIL; VARDENAFIL;

CLINICAL TRIAL; DOSAGE SCHEDULE COMPARISON; DRUG RESPONSE; DRUG UTILIZATION; ERECTILE DYSFUNCTION; EVENING DOSAGE; FOLLOW UP; HUMAN; METHODOLOGY; NOTE; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PENIS ERECTION; PRIORITY JOURNAL; PROSTATECTOMY; SEXUAL FUNCTION; SEXUAL INTERCOURSE; SEXUAL SATISFACTION;

EID: 58549112571     PISSN: 17434270     EISSN: 17434289     Source Type: Journal    
DOI: 10.1038/ncpuro1271     Document Type: Note

References (7)

1. Montorsi F et al. (1997) Recovery of spontaneous erectile function after nerve-sparing radical retropubic prostatectomy with and without early intracavernous injections of alprostadil: Results of a prospective, randomized trial. J Urol 158: 1408-1410
2. Padma-Nathan H et al. (2008) Randomized, double-blind, placebo-controlled study of postoperative nightly sildenafil citrate for the prevention of erectile dysfunction after bilateral nerve-sparing radical prostatectomy. Int J Impot Res 20: 479-486
3. Mulhall J et al. (2005) The use of an erectogenic pharmacotherapy regimen following radical prostatectomy improves recovery of spontaneous erectile function. J Sex Med 2: 532-540
4. Bannowsky A et al. (2008) Recovery of erectile function after nerve-sparing radical prostatectomy: Improvement with nightly low dose sildenafil. BJU Int 101: 1279-1283
5. Montorsi F et al. (2008) Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy. Eur Urol 54: 924-931
6. Teloken P et al. (2007) The correlation between erectile function and patient satisfaction. J Sex Med 4: 472-476
7. Ghofrani HA et al. (2004) Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension: A randomized prospective study. J Am Coll Cardiol 44: 1488-1496